If You'd Invested $1,000 in Mind Medicine ( MNMD ) Stock 5 Years Ago, Here's How Much You'd Have Today
Mind Medicine stock hasn't beaten the market over the last five years, but what comes next?
MindMed ( MNMD ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, July 31, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
MindMed Reports Strong Q2 2025 Results
Mind Medicine ( MindMed ) ( NASDAQ:MNMD ) reported Q2 2025 results on July 31, 2025. The company maintained strong enrollment momentum across all three pivotal phase 3 trials for MM120 ODT, confirmed a cash position of $237.9 million as of Q2 2025, sufficient to fund operations through 2027, and ...
Corporate Update, August 2025
NEW YORK, Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- From Dr. Neil Maresky, CEO, ...
MindMed ( MNMD ) Q2 Net Loss Jumps 625%
Mind Medicine ( MindMed ) ( NASDAQ:MNMD ) , a biopharmaceutical company developing psychedelic-inspired therapies for brain health disorders, reported its second quarter results on July 31, 2025. The company recorded a GAAP EPS loss of $0.50, wider than analyst expectations of $0.38.
Is Anixa Biosciences ( ANIX ) Stock Outpacing Its Medical Peers This Year?
Here is how ANIXA BIOSCIENCES INC (ANIX) and Mind Medicine (MindMed) Inc. (MNMD) have performed compared to their sector so far this year.
All You Need to Know About Mind Medicine MindMed ( MNMD ) Rating Upgrade to Buy
Mind Medicine MindMed (MNMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy
Expanded platform improves access, scales operations, and advances Incannex's position in next-generation mental health treatment Expanded platform improves access, scales operations, and advances Incannex's position in next-generation mental health treatment ...
Why Mind Medicine Gave Investors a Powerful Buzz in May
Mind Medicine ( NASDAQ: MNMD ) , a healthcare company that's looking to develop treatments based on psychedelic compounds, was something of a sleeper stock in May. Several positive developments pushed the highly specialized enterprise's share price higher, to the point where it closed the month ...
Wall Street Analysts Believe Mind Medicine MindMed ( MNMD ) Could Rally 237.47%: Here's is How to Trade
The mean of analysts' price targets for Mind Medicine MindMed (MNMD) points to a 237.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Why Mind Medicine Stock Vaulted More Than 8% Higher Today
Investors had a good mind to plow money into Mind Medicine ( NASDAQ: MNMD ) stock on Tuesday. Shares of the psychedelic-focused biotech, which also goes by the name of MindMed, provided a nice high by rising more than 8% in price on a legislative development.
Agilysys, Amer Sports, X Financial And Other Big Stocks Moving Higher On Tuesday - Amer Sports ( NYSE:AS ) , Agilysys ( NASDAQ:AGYS )
U.S. stocks were lower, with the Nasdaq Composite falling more than 50 points on Tuesday. Shares of Agilysys, Inc. AGYS rose sharply during Tuesday's session following better-than-expected fourth-quarter results.
Does Mind Medicine MindMed ( MNMD ) Have the Potential to Rally 279.84% as Wall Street Analysts Expect?
The mean of analysts' price targets for Mind Medicine MindMed (MNMD) points to a 279.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday - Burlington Stores ( NYSE:BURL ) , Costco Wholesale ( NASDAQ:COST )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wedbush raised Logitech International S.A. LOGI price target from $100 to $125.
Why Mind Medicine Stock Is Skyrocketing Today
Mind Medicine ( NASDAQ: MNMD ) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m. ET and had been up as much as 20.7% on the day earlier in the session.Mind Medicine's valuation is surging following Robert F.
This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Expand Energy ( NASDAQ:EXE ) , Albemarle ( NYSE:ALB )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Why Mind Medicine Stock Is Soaring Today
Mind Medicine ( NASDAQ: MNMD ) stock is posting big gains in Tuesday's trading. The biotech company's share price was up 8.7% as of 2 p.m. ET despite a 0.8% pullback for the S&P 500 index and a 1.5% decline for the Nasdaq Composite index.MindMed stock is surging today following a recent report ...
MindMed Stock Skyrockets 94% Year to Date: What's Driving It?
2024 was a transformational year for MNMD as it executed many important milestones.
5 Biotech Breakthrough Stocks to Watch in 2025
It is a good idea to keep an eye on five biotech breakthrough stocks, MDMD, BEAM, ACLX, OCGN and INSM, as they may give great returns in the next 2-3 years ...
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
Don't jump in without doing some research first.
5 Best-Performing ETFs of October
Wall Street delivered a muted performance in October. But these ETFs returned more than 10%.
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration - ATAI Life Sciences ( NASDAQ:ATAI ) , AbbVie ( NYSE:ABBV )
The global psychedelic drugs market is poised for significant growth over the next five years, with an estimated increase of USD 1.37 billion from 2024 to 2028, according to a report by Technavio.
Psychedelics Company MindMed Prices Public Offering Aiming To Raise $75M - Mind Medicine ( NASDAQ:MNMD )
A psychedelics-focused biopharmaceutical company Mind Medicine ( MindMed ) MNMD announced Friday the pricing of an underwritten public offering of 9.29 million shares without par value, at a price of $7.00 per share. Through this round, the New York-headquartered company aims to raise $75 million.
Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M - Mind Medicine ( NASDAQ:MNMD )
A promising new startup, Ovax Inc., secured $10 million in funding to advance the development of a groundbreaking vaccine designed to prevent fentanyl-related deaths. The initiative focuses on commercializing academic research aimed at preventing the potent opioid from reaching the brain, ...
Is Mind Medicine MindMed ( MNMD ) Outperforming Other Medical Stocks This Year?
Here is how Mind Medicine (MindMed) Inc. (MNMD) and ResMed (RMD) have performed compared to their sector so far this year.
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Regulators were not impressed by one company's petition for approval.
Three Stocks: Mind Medicine, CrowdStrike, and Hewlett Packard
Shares of Mind Medicine ( MNMD ) traded as much as 20% lower today in the wake of an announcement from an FDA advisory committee. The advisory committee issued a negative vote on a psychedelic treatment being developed by Lykos.
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - ATAI Life Sciences ( NASDAQ:ATAI ) , Cybin ( AMEX:CYBN )
A panel of advisors to the Food and Drug Administration ( FDA ) rejected MDMA as a treatment for post-traumatic stress disorder ( PTSD ) on Tuesday, citing a lack of evidence that the benefits would outweigh the risks of introducing the psychedelic treatment to patients.
Psychedelic Stocks Tank After FDA Advisors Shoot Down MDMA Therapy For PTSD
Shares for companies focused on psychedelic medicines plummeted during premarket trading on Wednesday after independent experts advised the Food and Drug Administration against approving psychedelic and stimulant drug MDMA, commonly known as ecstacy or molly, for post-traumatic stress disorder, ...
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - DouYu Intl Hldgs ( NASDAQ:DOYU )
U.S. stock futures were higher this morning, with the Dow futures gaining around 50 points on Wednesday. Shares of DouYu International Holdings Limited DOYU fell in today's pre-market trading following first-quarter results.
Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Stitch Fix ( NASDAQ:SFIX )
Shares of Stitch Fix, Inc. SFIX rose sharply in today's pre-market trading following better-than-expected third-quarter financial results. Stitch Fix reported quarterly losses of 18 cents per share which beat the analyst consensus estimate of losses of 24 cents by 25%.
Optimi Health Awarded Drug Establishment Licence From Health Canada
VANCOUVER, BC, June 3, 2024 /CNW/ - Optimi Health Corp. ( CSE: OPTI ) ( OTCQX: OPTHF ) ( FRA: 8BN ) ( "Optimi" or the "Company" ) , a leading Health Canada-licensed psychedelics pharmaceutical manufacturer specializing in controlled substances such as botanical psilocybin and MDMA, is pleased to ...
Three Stocks: American Airlines, Mind Medicine, and GameStop
American Airlines ( AAL ) shares closed the day 13% lower after the company adjusted their upcoming quarterly earnings expectations lower. The stock was the worst performer of all the S&P 500 stocks today.
Are Medical Stocks Lagging Mind Medicine MindMed ( MNMD ) This Year?
Here is how Mind Medicine (MindMed) Inc. (MNMD) and ResMed (RMD) have performed compared to their sector so far this year.
Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing - Moderna ( NASDAQ:MRNA )
On CNBC's "Mad Money Lightning Round," Jim Cramer believes in Moderna, Inc. MRNA. On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and announced a price target of $120. The "Mad Money" host likes Mind Medicine ( MindMed ) Inc.
Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Seritage Growth Props ( NYSE:SRG )
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday. Shares of Seritage Growth Properties SRG fell sharply in today's pre-market trading after the company reported a loss for the first quarter.
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher
For investors with a high level of risk tolerance, Mind Medicine could be an intriguing investment option.
Jim Cramer Slams Political Blocking Of 'LSD-Derived Antidepressants,' Citing Strong Test Data 'Showing They Worked' - ATAI Life Sciences ( NASDAQ:ATAI ) , Compass Pathways ( NASDAQ:CMPS )
Jim Cramer recently hyped up one of his guests in advance of his CNBC show "Mad Money," posting on X that people "will be very interested in MindMed for certain … LSD," and he made sure his interview did not disappoint. Mind Medicine Inc.
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday - Roblox ( NYSE:RBLX )
U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday. Shares of Roblox Corporation RBLX rose during Wednesday's session following reports the company has ramped up efforts to attract advertisers to its platform and made other moves to boost advertising sales.
MindMed ( MNMD ) Stock Rises 154% in 3 Months: Here's Why
MindMed's (MNMD) progress with the development of its lead candidate MM120 for treating generalized anxiety disorder has been encouraging, leading the stock to rise during this time.
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session - BlackBerry ( NYSE:BB ) , Simulations Plus ( NASDAQ:SLP ) , Levi Strauss ( NYSE:LEVI )
U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday. Shares of Simulations Plus, Inc. SLP rose sharply in today's pre-market trading after the company posted better-than-expected results for its second quarter.
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract - Optimi Health ( OTC:OPTHF )
VANCOUVER, British Columbia, April 02, 2024 ( GLOBE NEWSWIRE ) -- Optimi Health Corp.
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
Optimi Health secures Presenting Sponsorship at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston, MA.
MindMed's Set to Pass a Psychological Market Test
It's a little ironic ( strangely I hear Alanis Morissette singing that as I type ) that I'm talking about psychological levels with a psychedelic stock. Shares of Mind Medicine ( MNMD ) are preparing for one of the biggest moves a stock under $10 can make. The stock is setting up for a ...
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow - Mind Medicine ( NASDAQ:MNMD )
Welcome to a new episode of the Benzinga Psychedelics Podcast where we're joined by Robert Barrow, CEO of Mind Medicine ( MindMed ) MNMD, which has taken the development of LSD-based therapy to new heights.
Cybin ( CYBN ) Begins Phase II Study on Anxiety Drug, Stock Up
Cybin (CYBN) initiates a phase II proof-of-concept study evaluating CYB004 for the treatment of generalized anxiety disorder. The stock rises 7.2%.
Cortexa Leads the World in First Supply of Psilocybin Under the TGA's Authorized Prescriber Scheme
PharmAla's 50:50 Joint Venture with Vitura Health Limited, Cortexa, announces it is first entity to supply Psilocybin into Authorized Prescriber Scheme ...
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - Robinhood Markets ( NASDAQ:HOOD )
Shares of Robinhood Markets, Inc. HOOD rose sharply in today's pre-market trading after the company reported February trading metrics. After the market close on Wednesday, Robinhood said total funded customers grew to 23.6 million at the end of February, up approximately 130,000 from January.
Three Stocks: MindMed, Tesla, and Dollar Tree
What a ride it has been for Mind Medicine ( MNMD ) investors. We saw the stock shoot through the sky last week on news that the FDA had granted "Breakthrough Therapy Designation" to one of the company's trial treatments, but then shares dropped 30% from their highs.
Three Stocks: MindMed, Tesla, and Dollar Tree
What a ride it has been for Mind Medicine ( MNMD ) investors. We saw the stock shoot through the sky last week on news that the FDA had granted "Breakthrough Therapy Designation" to one of the company's trial treatments, but then shares dropped 30% from their highs.
